Yan Shanshan, Wang Yongnan, Feng Yingye, Guo Yujuan, Tang Huang, Gao Hongyi
Department of Pathology, Guangdong Women and Children Hospital, No. 521, Xingnan Avenue, Panyu District, Guangzhou, 511400, Guangdong, China.
Breast Disease Center, Guangdong Women and Children Hospital, No 521, Xingnan Avenue, Panyu District, Guangzhou, 511400, Guangdong, China.
Eur J Med Res. 2025 May 14;30(1):384. doi: 10.1186/s40001-025-02631-2.
A critical measure to reduce the risk of ipsilateral breast tumor recurrence after breast-conserving surgery (BCS) for patients with early invasive breast cancer (BC) is ensuring negative margins through frozen section intraoperative margin assessment (FSIMA).This study aims to evaluate the influencing factors and prognosis associated with positive initial margins in FSIMA.
The clinical data of 436 BC patients treated with BCS were retrospectively analyzed, and long-term follow-up outcomes were evaluated.
Among the 436 patients, approximately 90.8% (396/436) underwent successful BCS, while 71.8% (313/436) exhibited initial negative margins based on FSIMA. A total of 123 patients (28.2%) had positive initial margins, following additional excisions in some cases, 89 patients achieved negative margins. Univariate and multivariate analyses revealed significant differences between the positive and negative margin groups in tumor diameter, distance from the tumor to the nipple, and axillary lymph node metastasis (P < 0.05). No significant differences were observed in disease-free survival or overall survival between the two groups (P > 0.05).
The findings suggest that tumor diameter, the distance between the tumor and nipple, and axillary lymph node metastasis may influence the determination of positive initial margins in FSIMA. Positive initial margins do not appear to influence disease-free survival (DFS) or overall survival (OS) among BC patients treated with BCS.
对于早期浸润性乳腺癌(BC)患者,保乳手术(BCS)后降低同侧乳腺肿瘤复发风险的一项关键措施是通过术中冰冻切片切缘评估(FSIMA)确保切缘阴性。本研究旨在评估FSIMA中初始切缘阳性的相关影响因素及预后。
回顾性分析436例接受BCS治疗的BC患者的临床资料,并评估长期随访结果。
在436例患者中,约90.8%(396/436)成功接受了BCS,而基于FSIMA,71.8%(313/436)的患者初始切缘为阴性。共有123例患者(28.2%)初始切缘阳性,部分病例经再次切除后,89例患者切缘转为阴性。单因素和多因素分析显示,切缘阳性组和阴性组在肿瘤直径、肿瘤距乳头的距离以及腋窝淋巴结转移方面存在显著差异(P<0.05)。两组在无病生存率或总生存率方面未观察到显著差异(P>0.05)。
研究结果表明,肿瘤直径、肿瘤与乳头之间的距离以及腋窝淋巴结转移可能影响FSIMA中初始切缘阳性的判定。初始切缘阳性似乎不会影响接受BCS治疗的BC患者的无病生存(DFS)或总生存(OS)。